Epigenetic Study Identifies Potential Drug Targets for a Rare Type of Bone Marrow Cancer
There are many treatment options for cancer today, yet it continues to be a major health problem, killing hundreds of thousands of people in the US each year. While conventional therapies like chemo and radiation have successfully extended survival rates, they don’t necessarily work for all patients, especially those with late-stage or rare cancers. As a result, more advanced treatments and diagnostic methods are being sought after to stem the cancer death toll. One research area that shows great promise [more…]